Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Insulet, Eli Lilly enter agreement to help patients with type 2 diabetes

Insulet Corp., a medical device company based in Bedford, will develop a pump specifically designed to deliver a concentrated form of insulin made by Eli Lilly and Co. for diabetics who need the drug in high doses, the two companies said Thursday.

Insulet makes a tubeless insulin pump known as the OmniPod Insulin Management System. The OmniPod is a small pump about half the size of a hard-boiled egg. Diabetics wear the pump, which uses an adhesive to stick to such places as shoulder blades and the side of the stomach. According to Insulet, the OmniPod system, is lighter, more convenient, and more effective for patients than earlier-generation insulin pumps.

Continue reading below

As the incidence of severe insulin resistance continues to rise, more and more people with type 2 diabetes are requiring significantly higher doses of insulin in order to control their blood glucose, Insulet and Eli Lilly said in their press release. It was for this group of patients that Eli Lilly developed Humulin R U-500, a concentrated form of insulin.

Under Thursday’s agreement, Insulet will develop a new version of the OmniPod that is specifically designed to for use with Humulin R U-500.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week